MKNK2 and cancer: In addition, phospho-MNK1 (at Thr197/202, Thr255, and Thr385 sites) and phospho-MNK2 (at Thr249 site) were markedly increased across cancer cells, relative to ASC52telo and HUtSMC cells (Fig. 1a).